LYRA THERAPEUTICS INC (LYRA)
US55234L1052 - Common Stock
ChartMill assigns a Buy % Consensus number of 75% to LYRA. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 1.27. This target is 628.57% above the current price.
LYRA was analyzed by 11 analysts. The buy percentage consensus is at 75. So analysts seem to be have mildly positive about LYRA.
In the previous month the buy percentage consensus was at a similar level.
LYRA was analyzed by 11 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-08-15 | Cantor Fitzgerald | Reiterate | Overweight |
| 2024-08-15 | HC Wainwright & Co. | Reiterate | Neutral -> Neutral |
| 2024-06-20 | Cantor Fitzgerald | Reiterate | Overweight |
| 2024-05-07 | Jefferies | Downgrade | Buy -> Hold |
| 2024-05-07 | HC Wainwright & Co. | Downgrade | Buy -> Neutral |
| 2024-05-06 | BTIG | Downgrade | Buy -> Neutral |
| 2024-05-01 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-03-25 | B of A Securities | Maintains | Buy -> Buy |
| 2024-03-22 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-10-02 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-09-12 | B of A Securities | Maintains | Buy -> Buy |
| 2023-08-31 | HC Wainwright & Co. | Initiate | Buy |
| 2023-02-07 | BTIG | Maintains | Buy |
| 2022-05-24 | Cantor Fitzgerald | Initiate | Overweight |